Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
CLVT 
CLARIVATE PLC (CLVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $4.93
1 Year Target Price $4.93
| 3 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -62.42% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/09/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.49B USD | Price to earnings Ratio - | 1Y Target Price 4.93 |
Price to earnings Ratio - | 1Y Target Price 4.93 | ||
Volume (30-day avg) 10 | Beta 1.52 | 52 Weeks Range 3.04 - 5.74 | Updated Date 12/8/2025 |
52 Weeks Range 3.04 - 5.74 | Updated Date 12/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.57 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -15.83% | Operating Margin (TTM) 7.17% |
Management Effectiveness
Return on Assets (TTM) 0.99% | Return on Equity (TTM) -7.6% |
Valuation
Trailing PE - | Forward PE 5.48 | Enterprise Value 6555494949 | Price to Sales(TTM) 1 |
Enterprise Value 6555494949 | Price to Sales(TTM) 1 | ||
Enterprise Value to Revenue 2.62 | Enterprise Value to EBITDA 9.08 | Shares Outstanding 661435069 | Shares Floating 386622027 |
Shares Outstanding 661435069 | Shares Floating 386622027 | ||
Percent Insiders 16.96 | Percent Institutions 89.55 |
Upturn AI SWOT
CLARIVATE PLC
Company Overview
History and Background
Clarivate Plc (CLVT) was established in 2016 as a spin-off from Thomson Reuters. It focuses on providing critical data, analytics, and workflow solutions to professionals in science, research, and innovation. Major milestones include its IPO on the New York Stock Exchange in 2019 and significant acquisitions like Techstreet and DRIC in recent years. The company aims to be a leading platform for accelerating innovation.
Core Business Areas
- Academic & Government: Provides solutions for academic institutions and government bodies to enhance research discovery, collaboration, and impact. This includes tools for grant management, researcher profiling, and bibliometric analysis.
- Life Sciences & Health Care: Offers data and analytics for pharmaceutical, biotechnology, and medical device companies. Products help with drug discovery, clinical trial management, regulatory compliance, and market intelligence.
- Intellectual Property: Delivers comprehensive patent and trademark solutions for IP professionals. This encompasses patent searching, portfolio management, competitive intelligence, and litigation support.
- Customer & Market Intelligence: Provides market research and competitive intelligence tools for various industries, enabling businesses to understand market trends, customer behavior, and competitive landscapes.
Leadership and Structure
Clarivate Plc is led by a management team comprising a Chief Executive Officer, Chief Financial Officer, and heads of various business segments. The company operates as a publicly traded entity with a board of directors overseeing its strategic direction.
Top Products and Market Share
Key Offerings
- Product Name 1: Cortellis (Life Sciences Intelligence) - Provides comprehensive data and analytics for drug discovery, development, and commercialization. Competitors include IQVIA, GlobalData, and Symphony Health Solutions. Specific market share data is proprietary, but it's a leading platform in its niche.
- Product Name 2: Derwent (Intellectual Property Solutions) - Offers patent search, analysis, and management tools. Key competitors include LexisNexis, Questel, and PatSnap. It's a significant player in the IP analytics market.
- Product Name 3: Web of Science (Research Intelligence) - A citation indexing service and research platform used by academic and research institutions globally. Competitors include Scopus (Elsevier) and Google Scholar. It holds a strong position in academic bibliometrics.
Market Dynamics
Industry Overview
Clarivate operates within the broader information services, analytics, and data management industries. These sectors are characterized by a strong demand for specialized data, insights, and workflow automation, driven by R&D investments, intellectual property protection needs, and market competition across various verticals like life sciences, technology, and academia.
Positioning
Clarivate is positioned as a leading provider of mission-critical information and analytics for professionals in research, innovation, and IP. Its competitive advantages lie in its comprehensive data sets, integrated workflow solutions, and strong brand recognition in its core segments. The company leverages its extensive historical data and analytical capabilities to offer deep insights.
Total Addressable Market (TAM)
The TAM for data, analytics, and workflow solutions in Clarivate's target markets (life sciences, IP, academia, etc.) is estimated to be in the tens of billions of dollars and is continuously growing due to increasing data generation and the need for advanced analytics. Clarivate aims to capture a significant portion of this TAM by providing integrated solutions across its diverse business units.
Upturn SWOT Analysis
Strengths
- Strong brand recognition and established customer base in core segments (e.g., Web of Science, Derwent).
- Comprehensive and proprietary datasets across research, IP, and life sciences.
- Integrated workflow solutions that enhance customer productivity.
- Diversified revenue streams across multiple verticals.
- Experienced management team with a track record in information services.
Weaknesses
- Reliance on acquisitions for growth, which can lead to integration challenges and debt.
- Potential for customer churn in subscription-based models if value proposition weakens.
- Complex organizational structure due to various acquisitions.
- Competition from specialized niche players and larger diversified tech companies.
Opportunities
- Expansion into emerging markets and new geographic regions.
- Leveraging AI and machine learning to enhance analytical capabilities and develop new products.
- Cross-selling opportunities across its diverse product portfolio.
- Growth in demand for data and analytics in areas like sustainability and ESG.
- Further consolidation within the information services industry.
Threats
- Intensifying competition from both established players and agile startups.
- Changes in regulatory environments affecting data privacy and IP protection.
- Economic downturns impacting R&D spending and IT budgets of clients.
- Cybersecurity risks and data breaches.
- Technological disruptions that could make existing products obsolete.
Competitors and Market Share
Key Competitors
- RELX PLC (XLS)
- S&P Global Inc. (SPGI)
- Elsevier (part of RELX PLC)
- IQVIA Holdings Inc. (IQV)
Competitive Landscape
Clarivate competes with larger, diversified information providers like RELX and S&P Global, which have broader portfolios and greater financial resources. It also faces specialized competitors within its niche segments, such as IQVIA in life sciences. Clarivate's advantage lies in its focused expertise and integrated workflow solutions tailored to research, IP, and innovation professionals.
Major Acquisitions
Techstreet
- Year: 2020
- Acquisition Price (USD millions): 170
- Strategic Rationale: To expand its offering of technical and industry standards content, complementing its existing product portfolio and serving a broader base of engineering and research professionals.
DRIC (Data, Research, Innovation and Collaboration) by Property Informer
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: To enhance its intellectual property solutions with advanced data analytics and visualization tools for IP professionals, improving search and analysis capabilities.
ProQuest
- Year: 2021
- Acquisition Price (USD millions): 5200
- Strategic Rationale: A transformative acquisition aimed at creating a leading global information services provider, significantly expanding Clarivate's presence in academic research, library solutions, and historical archives.
Growth Trajectory and Initiatives
Historical Growth: Clarivate has experienced growth through a combination of organic expansion of its existing businesses and strategic acquisitions. Its history involves integrating diverse companies and product lines to build a comprehensive platform.
Future Projections: Analyst projections for Clarivate's future growth typically focus on continued expansion of its data and analytics offerings, leveraging technological advancements like AI, and further market penetration in key sectors. Growth is expected to be driven by both recurring revenue and new product development.
Recent Initiatives: Recent initiatives have included targeted acquisitions to bolster specific business segments, investments in technology to enhance platform capabilities, and efforts to streamline operations and improve customer integration post-acquisition.
Summary
Clarivate Plc is a significant player in the information services sector, focusing on research, IP, and life sciences. Its strengths lie in its comprehensive data, integrated platforms, and strong brand recognition in niche markets. However, its reliance on acquisitions and integration challenges present ongoing risks. Opportunities exist in AI integration and market expansion, while competitive pressures and economic uncertainties pose threats. Overall, the company shows potential for growth but needs to carefully manage its acquisition strategy and operational integration.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Relations Websites
- Financial News and Analysis Platforms
- Market Research Reports (general industry data)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Market share data for specific products is often proprietary and estimations are used. Financial performance and projections are subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com | ||
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.